MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0099208
Maclive Pharmaceuticals Private Limited
Maclive Pharmaceuticals Private Limited - jewelry & fashion accessories in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.03 Lakh
▲ 7% YoY
Net loss · FY 2025
₹1.23 Lakh
Net margin -2.1%
EBITDA · FY 2025
₹2.7 Lakh
EBITDA margin 4.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹4 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Maclive Pharmaceuticals Private Limited
Data last updated:
Maclive Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 22 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33309TG2020PTC138594. Its GSTIN is 23AANCM2613D1ZW (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashish Mohar and Sonal Mohar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat. No.506 Block Peony Ananda Homes 332/P Poetree Apartment Narsingi Gandi, Hyderabad, Telangana, India – 500089.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.03 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1.23 Lakh (net margin -2.1%) and EBITDA of ₹2.7 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
As per MCA filings, the company has open charges of ₹4 Lakh on record.
Maclive Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0099208).
Company details
CIN U33309TG2020PTC138594
Registration Number 138594
Incorporation Date 22 January 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0099208
Recognitions & Rankings of Maclive Pharmaceuticals
Contact details
Maclive Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat. No.506 Block Peony Ananda Homes 332/P Poetree Apartment Narsingi Gandi, Hyderabad, Telangana, India – 500089
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
To see the full contact details of Maclive Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Maclive Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maclive Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maclive Pharmaceuticals Private Limited, buy the company report.
Financials of Maclive Pharmaceuticals Private Limited
FY 2025 filings availableMaclive Pharmaceuticals Private Limited reported revenue of ₹60.03 Lakh (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹60.03 Lakh ▲ 7%
Net loss · FY 2025
₹1.23 Lakh margin -2.1%
EBITDA · FY 2025
₹2.7 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 22%
5 years · compounded
▲ 76%
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years, including 7% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | -2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maclive Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maclive Pharmaceuticals Private Limited
Maclive Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Mohar | Director | 22 Jan 2020 | 6 Years 9 Months | Current |
| Sonal Mohar | Director | 22 Jan 2020 | 6 Years 9 Months | Current |
| Jugal Kishore Mohar | Director | 30 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Maclive Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oberto Pharmaceuticals Private Limited | ₹60.15 Lakh (FY 2020) | 266.0% | Manimajra, Chandigarh, India | |||
| Divergent Pharmaceuticals Private Limited | ₹60.12 Lakh (FY 2025) | 13.0% | Bhopal, Madhya Pradesh, India | |||
| Dewey Pharmaceuticals Private Limited | ₹60.03 Lakh (FY 2024) | 60.0% | Guwahati, Assam, India | |||
| Maclive Pharmaceuticals Private Limitedthis company | ₹60.03 Lakh (FY 2025) | -₹1.23 Lakh | -2.1% | 7.0% | Hyderabad, Telangana, India | |
| Snufi Pharmaceuticals Private Limited | ₹59.83 Lakh (FY 2024) | 45.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Maclive Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2023 | 100766381 | Hdfc Bank Limited | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Maclive Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maclive Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maclive Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AANCM2613D1ZW | Madhya Pradesh | Active | 16 Apr 2020 |
To see the full GST registrations and return filing status of Maclive Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maclive Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Jugal Kishore Mohar was appointed as Director on 30 Mar 2020.
AGM
Maclive Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maclive Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Lakh with Charge ID 100766381 was registered on 24 Jul 2023.
Appointed
Jugal Kishore Mohar was appointed as Director.
Appointed
Ashish Mohar was appointed as Director.
Appointed
Sonal Mohar was appointed as Director.
Incorporation
22 Jan 2020
Maclive Pharmaceuticals Private Limited was registered on 22 Jan 2020 with Roc Hyderabad & aged 6 years 9 months as per MCA records.
Frequently asked questions
Maclive Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 22 January 2020 (6+ years old) and is registered under CIN U33309TG2020PTC138594.
Maclive Pharmaceuticals has 3 current directors:
- Ashish Mohar - Director
- Sonal Mohar - Director
- Jugal Kishore Mohar - Director
The latest financial statements of Maclive Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Maclive Pharmaceuticals is 23AANCM2613D1ZW, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Maclive Pharmaceuticals is U33309TG2020PTC138594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maclive Pharmaceuticals was incorporated on 22 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Maclive Pharmaceuticals by revenue are Oberto Pharmaceuticals Private Limited, Divergent Pharmaceuticals Private Limited, Dewey Pharmaceuticals Private Limited, Snufi Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jugal Kishore Mohar was appointed as Director on 30 Mar 2020. Ashish Mohar was appointed as Director on 22 Jan 2020. Sonal Mohar was appointed as Director on 22 Jan 2020.
Yes, Maclive Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0099208).
The registered office of Maclive Pharmaceuticals is at Flat. No.506 Block Peony Ananda Homes 332P Poetree Apartment Narsingi Gandi, Hyderabad, Telangana, India – 500089.
Maclive Pharmaceuticals operates in the jewelry and fashion accessories industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages